$8.26 Million is the total value of Copernicus Capital Management, LLC's 13 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 163.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | New | PFIZER INC | $1,290,000 | – | 30,000 | +100.0% | 15.61% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $1,143,000 | – | 2,000 | +100.0% | 13.83% | – |
| TDOC | New | TELADOC HEALTH INC | $888,000 | – | 7,000 | +100.0% | 10.75% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $850,000 | – | 11,000 | +100.0% | 10.29% | – |
| JNJ | New | JOHNSON & JOHNSON | $808,000 | – | 5,000 | +100.0% | 9.78% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $711,000 | -18.1% | 12,000 | +20.0% | 8.60% | -37.1% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $657,000 | +40.4% | 6,000 | +20.0% | 7.95% | +7.7% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $593,000 | +259.4% | 17,000 | -15.0% | 7.18% | +175.8% |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $386,000 | – | 15,000 | +100.0% | 4.67% | – |
| MDT | New | MEDTRONIC PLC | $376,000 | – | 3,000 | +100.0% | 4.55% | – |
| PRQR | New | PROQR THRAPEUTICS N V | $335,000 | – | 40,000 | +100.0% | 4.05% | – |
| IMTX | New | IMMATICS N.V | $130,000 | – | 10,000 | +100.0% | 1.57% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $96,000 | – | 10,000 | +100.0% | 1.16% | – |
| SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -10,000 | -100.0% | -2.65% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -35,000 | -100.0% | -5.05% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -2,000 | -100.0% | -5.60% | – |
| ACCD | Exit | ACCOLADE INC | $0 | – | -7,000 | -100.0% | -5.99% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -7.76% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -8.39% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -12.27% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -9,000 | -100.0% | -28.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.